Announcements Trials
Browse Landscape

Phase

Phase NA 38Phase 1 26Phase 2 22Phase 1/2 13Phase 4 6Phase 3 5Phase EARLY_PHASE1 2Phase 2/3 2

Status

Completed 39Unknown 13Terminated 7Active not recruiting 6Recruiting 5Not yet recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 129Carcinoma, Non-Small-Cell Lung 101Prostatic Neoplasms 62Colorectal Neoplasms 49Nasopharyngeal Carcinoma 46Neoplasms 43Multiple Myeloma 41Stomach Neoplasms 34Lung Neoplasms 32Ovarian Neoplasms 31Neoplasm Metastasis 31Leukemia, Myeloid, Acute 31Carcinoma, Hepatocellular 29Squamous Cell Carcinoma of Head and Neck 27Rectal Neoplasms 27Triple Negative Breast Neoplasms 25Recurrence 25Pancreatic Neoplasms 25Small Cell Lung Carcinoma 21Esophageal Neoplasms 21Brain Neoplasms 21Uterine Cervical Neoplasms 20Colonic Neoplasms 20Lymphoma, Large B-Cell, Diffuse 18Head and Neck Neoplasms 17Urinary Bladder Neoplasms 16Leukemia, Lymphocytic, Chronic, B-Cell 16Esophageal Squamous Cell Carcinoma 16Carcinoma, Renal Cell 16Myasthenia Gravis 15

Interventions

ferric carboxymaltose 12-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Liver Neoplasms × Clear all
NCT05201404 2025-04-29

LIVERATION

Can-Fite BioPharma

Phase 3 Recruiting
471 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT06555003 2025-04-23

CLEAR-DEBIRI

Tehran University of Medical Sciences

Phase 3 Recruiting
116 enrolled
Gastrointestinal

Liver Neoplasms

NCT05744219 2024-10-21

IRIS

Uppsala University Hospital

Phase 3 Recruiting
338 enrolled
Gastrointestinal

Aortic Aneurysm, Liver Neoplasms, Pancreatic Neoplasms

NCT04868149 2024-08-15

Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS

The University of Hong Kong

Phase 3 Recruiting
40 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03949231 2024-06-26

Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma

Second Affiliated Hospital of Guangzhou Medical University

Phase 3 Recruiting
200 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡